中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

急性胰腺炎合并代谢综合征的临床特征及预后影响因素分析

钟瑞 严永峰 蒋鑫 徐欢 彭燕 汪敏 付文广 汤小伟

刘益均, 吴乔. 内镜逆行胰胆管造影术中使用SpyGlass系统联合液电碎石治疗胆总管困难结石的效果及安全性分析[J]. 临床肝胆病杂志, 2021, 37(7): 1644-1647. DOI: 10.3969/j.issn.1001-5256.2021.07.032.
引用本文: 刘益均, 吴乔. 内镜逆行胰胆管造影术中使用SpyGlass系统联合液电碎石治疗胆总管困难结石的效果及安全性分析[J]. 临床肝胆病杂志, 2021, 37(7): 1644-1647. DOI: 10.3969/j.issn.1001-5256.2021.07.032.
LIU YJ, W Q. Efficacy and safety of SpyGlass system combined with electrohydraulic lithotripsy during endoscopic retrograde cholangiopancreatography in treatment of difficult common bile duct stones[J]. J Clin Hepatol, 2021, 37(7): 1644-1647. DOI: 10.3969/j.issn.1001-5256.2021.07.032.
Citation: LIU YJ, W Q. Efficacy and safety of SpyGlass system combined with electrohydraulic lithotripsy during endoscopic retrograde cholangiopancreatography in treatment of difficult common bile duct stones[J]. J Clin Hepatol, 2021, 37(7): 1644-1647. DOI: 10.3969/j.issn.1001-5256.2021.07.032.

急性胰腺炎合并代谢综合征的临床特征及预后影响因素分析

DOI: 10.3969/j.issn.1001-5256.2020.08.023
基金项目: 

泸州市科技局基金(17246); 泸州市三方联合基金(Z1437); 西南医科大学附属医院科研基金(07037);西南医科大学附属医院博士启动基金(16229); 泸州市人民政府西南医科大学科技战略合作项目(2019LZXNYDJ24); 

详细信息
  • 中图分类号: R576;R589

Clinical features of acute pancreatitis with metabolic syndrome and influencing factors for prognosis

Research funding: 

 

  • 摘要:

    目的探讨合并代谢综合征(MS)的急性胰腺炎(AP)患者临床特征及预后影响因素。方法回顾性分析2013年1月-2019年1月西南医科大学附属医院收治的590例AP患者的临床资料,根据有无MS分为MS组(n=178)和非MS组(n=412),比较两组患者的基本临床特征;根据AP严重程度分为轻型急性胰腺炎(MAP)(n=317)、中度重型急性胰腺炎(MSAP)(n=171)、重型急性胰腺炎(SAP)(n=102),比较3组患者的MS成分指标。符合正态分布的计量资料两组间比较采用t检验,多组间比较采用单因素方差分析;不符合正态分布的计量资料两组间比较采用Mann-Whitney U检验,多组间比较采用Kruskal-Wallis H检验。进一步两两比较均采用Bonferroni校正法。计数资料组间比较采用χ2检验,单向有序分类资料采用趋势χ2检验,双向有序分类资料采用Goodman-Kruskal Gamma分析。有序logistic回归分析评估BMI与AP严重程度的关系;二分类logistic回归分析MS与AP严重程度的关系。结果 MS合并AP最常...

     

  • [1] Pancreas Study Group,Chinese Society of Gastroenterology,Chinese Medical Association; Editorial Board of Chinese Journal of Pancreatology; Editorial Board of Chinese Journal of Digestion. Chinese guidelines for the management of acute pancreatitis(Shenyang,2019)[J]. J Clin Hepatol,2019,35(12):2706-2711.(in Chinese)中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编委会,《中华消化杂志》编委会.中国急性胰腺炎诊治指南(2019年,沈阳)[J].临床肝胆病杂志,2019,35(12):2706-2711.
    [2] BANKS PA,BOLLEN TL,DERVENIS C,et al. Classification of acute pancreatitis—2012:Revision of the Atlanta classification and definitions by international consensus[J]. Gut,2013,62(1):102-111.
    [3] Metabolic Syndrome Research Collaboration Group from Chinese Diabetes Society. Suggestions on metabolic syndrome from Chinese Diabetes Society[J]. Chin J Diabetes,2004,12(3):156-161.(in Chinese)中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中华糖尿病杂志,2004,12(3):156-161.
    [4] PREZ-MARTNEZ P,MIKHAILIDIS DP,ATHYROS VG,et al. Lifestyle recommendations for the prevention and management of metabolic syndrome:An international panel recommendation[J]. Nutr Rev,2017,75(5):307-326.
    [5] CORNIER MA,DABELEA D,HERNANDEZ TL,et al. The metabolic syndrome[J]. Endocr Rev,2008,29(7):777-822.
    [6] SHEN XB,YIN Y. The relationship between metabolic syndrome and prognosis of patients with acute cerebral infarction[J]. Traum Crit Med,2019,7(3):184-186.(in Chinese)沈小波,殷艳.代谢综合征与急性脑梗死患者预后关系研究[J].创伤与急危重病医学,2019,7(3):184-186.
    [7] DOBSZAI D,MTRAI P,GYNGYI Z,et al. Body-mass index correlates with severity and mortality in acute pancreatitis:A meta-analysis[J]. World J Gastroenterol,2019,25(6):729-743.
    [8] SAWALHI S,AL-MARAMHY H,ABDELRAHMAN AI,et al.Does the presence of obesity and/or metabolic syndrome affect the course of acute pancreatitis? A prospective study[J].Pancreas,2014,43(4):565-570.
    [9] KRISHNA SG,HINTON A,OZA V,et al. Morbid obesity is associated with adverse clinical outcomes in acute pancreatitis:A propensity-matched study[J]. Am J Gastroenterol,2015,110(11):1608-1619.
    [10] GREGOR MF,HOTAMISLIGIL GS. Inflammatory mechanisms in obesity[J]. Annu Rev Immunol,2011,29(1):415-445.
    [11] HENAO-MEJIA J,ELINAV E,JIN C,et al. Inflammasomemediated dysbiosis regulates progression of NAFLD and obesity[J]. Nature,2012,482(7384):179-185.
    [12] KHATUA B,EL-KURDI B,SINGH VP. Obesity and pancreatitis[J]. Curr Opin Gastroenterol,2017,33(5):374-382.
    [13] VARELA JE,HINOJOSA M,NGUYEN N. Correlations between intra-abdominal pressure and obesity-related co-morbidities[J]. Surg Obes Relat Dis,2009,5(5):524-528.
    [14] SADR-AZODI O,ORSINI N,ANDRN-SANDBERG A,et al. Abdominal and total adiposity and the risk of acute pancreatitis:A population-based prospective cohort study[J].Am J Gastroenterol,2013,108(1):133-139.
    [15] DING Y,ZHANG M,WANG L,et al. Association of the hypertriglyceridemic waist phenotype and severity of acute pancreatitis[J]. Lipids Health Dis,2019,18(1):93.
    [16] FREITAS RS,FONSECA MJMD,SCHMIDT MI,et al. Hypertriglyceridemic waist phenotype:Associated factors and comparison with other cardiovascular and metabolic risk indicators in the ELSA-Brasil study[J]. Cad Saude Publica,2018,34(4):e00067617.
    [17] ZHANG Y,GUO F,LI S,et al. Decreased high density lipoprotein cholesterol is an independent predictor for persistent organ failure,pancreatic necrosis and mortality in acute pancreatitis[J]. Sci Rep,2017,7(1):8064.
    [18] ZHOU CL,ZHANG CH,ZHAO XY,et al. Early prediction of persistent organ failure by serum apolipoprotein A-I and high-density lipoprotein cholesterol in patients with acute pancreatitis[J]. Clin Chim Acta,2018,476:139-145.
    [19] SILVA-VAZ P,ABRANTES AM,CASTELO-BRANCO M,et al. Multifactorial scores and biomarkers of prognosis of acute pancreatitis:Applications to research and practice[J].Int J Mol Sci,2020,21(1):e338.
  • 期刊类型引用(12)

    1. 陶丽莹,王宏光,郭庆梅,朴连玉,郭享,阮丽斌,刘时助,孙震. 内镜逆行胰胆管造影联合eyeMax胆胰成像系统直视下液电碎石治疗困难胆管结石效果观察. 临床肝胆病杂志. 2024(02): 351-355 . 本站查看
    2. 刘姣,朱巧,范建梅. 内镜逆行胰胆管造影术中使用胰胆直视成像系统联合激光碎石治疗胆总管复杂结石的分析. 医学研究与战创伤救治. 2024(02): 177-180 . 百度学术
    3. 刘晓艳,杨亚苹,韩文雄. 多层螺旋计算机断层扫描技术与磁共振胰胆管造影技术诊断胆总管结石的临床价值. 包头医学. 2024(02): 10-12 . 百度学术
    4. 马丽娜·阿新拜,张立平,王林恒,王允亮,陈润花,孟捷,胡立明,姚玉璞. 经ERCP联合SpyGlass DS治疗的74例不明原因胆管狭窄患者的临床特征分析. 胃肠病学和肝病学杂志. 2024(08): 1037-1044 . 百度学术
    5. 艾合买江·库尔班江,布娅·米然别克,王秋玲,李得阳,高峰. SpyGlass DS系统联合激光碎石法与常规分次治疗胆总管大结石的效果和安全性的对比分析. 中国内镜杂志. 2024(08): 12-17 . 百度学术
    6. 郭志新,王俊,余晓,关天佑,于芳芳. NTrap网篮联合输尿管软镜钬激光术治疗上段输尿管结石的效果及预后观察. 医药论坛杂志. 2024(16): 1703-1707 . 百度学术
    7. 叶国华,姜继豪,王小方. 腹腔镜下联合胆道镜、术中超声及液电碎石仪治疗复杂肝内胆管结石的效果. 中国当代医药. 2024(31): 20-23 . 百度学术
    8. 刘杨军,李纪男. ERCP治疗高龄胆总管结石的效果. 中国老年学杂志. 2024(24): 5935-5937 . 百度学术
    9. 王毅兰,李喆楠,王军民. SpyGlass在胆胰疾病诊治中的研究进展. 河北医科大学学报. 2023(02): 241-245 . 百度学术
    10. 刘炯,汪向飞,江斌. SpyGlass系统在困难胆囊腹腔镜胆囊切除术中的应用价值. 临床外科杂志. 2023(10): 925-927 . 百度学术
    11. 濮天,陈江明,郭旗,蒋东,李子寒,刘付宝,耿小平. 精准肝切除术治疗复发性单侧肝内胆管结石的临床疗效及预后影响因素分析. 中华消化外科杂志. 2022(02): 273-280 . 百度学术
    12. 陈安,柏强善,谭凯. 对胆囊结石合并胆总管结石的老年患者实施腹腔镜胆囊切除术联合内镜逆行胰胆管造影术的临床疗效. 中国内镜杂志. 2022(11): 57-64 . 百度学术

    其他类型引用(4)

  • 加载中
计量
  • 文章访问数:  1629
  • HTML全文浏览量:  34
  • PDF下载量:  162
  • 被引次数: 16
出版历程
  • 出版日期:  2020-08-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回